tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Alnylam price target raised to $489 from $449 at Piper Sandler
PremiumThe FlyAlnylam price target raised to $489 from $449 at Piper Sandler
1M ago
Alnylam price target raised to $527 from $460 at Barclays
Premium
The Fly
Alnylam price target raised to $527 from $460 at Barclays
1M ago
Alnylam price target raised to $475 from $400 at Chardan
Premium
The Fly
Alnylam price target raised to $475 from $400 at Chardan
1M ago
Alnylam price target lowered to $549 from $550 at Jefferies
PremiumThe FlyAlnylam price target lowered to $549 from $550 at Jefferies
1M ago
Alnylam Pharma: Strong Sales Growth and Financial Performance Justify Buy Rating
Premium
Ratings
Alnylam Pharma: Strong Sales Growth and Financial Performance Justify Buy Rating
1M ago
Alnylam reports Q3 EPS $1.84, consensus $1.75
Premium
The Fly
Alnylam reports Q3 EPS $1.84, consensus $1.75
1M ago
Alnylam price target raised to $475 from $405 at Morgan Stanley
PremiumThe FlyAlnylam price target raised to $475 from $405 at Morgan Stanley
2M ago
Alnylam price target raised to $495 from $441 at Stifel
Premium
The Fly
Alnylam price target raised to $495 from $441 at Stifel
2M ago
Alnylam Pharma Secures $500M Credit Agreement
Premium
Company Announcements
Alnylam Pharma Secures $500M Credit Agreement
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100